Joost A. P. Leijte
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Joost A. P. Leijte has a total of 4 co-authors. Here are the top co-authors by number of shared publications:
Omgo E. Nieweg
1 shared publicationRenato A. Valdés Olmos
1 shared publicationSimon Horenblas
1 shared publication- Simon Horenblas
Department of Urology, The Netherlands Cancer Institute, Amsterdam, The Netherlands
1 shared publication
Latest Publications
- 1 October 2008
- Published by Elsevier in European Urology
- Vol. 54 (4) , 885-892
Anatomical Mapping of Lymphatic Drainage in Penile Carcinoma with SPECT-CT: Implications for the Extent of Inguinal Lymph Node Dissection
- 1 October 2008
- Published by Elsevier in European Urology
- Vol. 54 (4) , 885-892
Anatomical Mapping of Lymphatic Drainage in Penile Carcinoma with SPECT-CT: Implications for the Extent of Inguinal Lymph Node Dissection
- Open Access
- 9 August 2008
- Published by Springer Nature in World Journal of Urology
- Vol. 27 (2) , 151-154
Shortcomings of the current TNM classification for penile carcinoma: time for a change?
Accurate tumor staging is essential in the management of malignancies. It provides a guide in selecting accurate treatment and gives an indication of prognosis based on the extent of disease. The current TNM classification for penile carcinoma has remained unchanged since 1987. In this article, we focus on several deficiencies of the current classification. An analysis of the current literature regarding the current classification was done, focusing on known prognostic factors for survival. Furthermore, we discuss in detail the results from a recent analysis of more than 500 patients treated at our institute to evaluate the practical and prognostic value of the TNM-classification. We found that, using the current classification system, accurate clinical staging is often difficult, because the T and N categories are defined by structures that are not easily identified using physical examination or imaging. Furthermore, the prognostic stratification of the present staging system is not optimal and there is a substantial overlap in disease-specific survival between several categories. We give an overview of modifications that could improve clinical staging and prognostic ability. The current TNM classification for penile carcinoma has several shortcomings in terms of usability in clinical staging and prognostic value. With modifications clinical staging is facilitated, while the prognostic stratification of the classification is improved.
- 9 August 2008
- Published by Springer Nature in World Journal of Urology
- Vol. 27 (2) , 151-154
Open AccessShortcomings of the current TNM classification for penile carcinoma: time for a change?
Accurate tumor staging is essential in the management of malignancies. It provides a guide in selecting accurate treatment and gives an indication of prognosis based on the extent of disease. The current TNM classification for penile carcinoma has remained unchanged since 1987. In this article, we focus on several deficiencies of the current classification. An analysis of the current literature regarding the current classification was done, focusing on known prognostic factors for survival. Furthermore, we discuss in detail the results from a recent analysis of more than 500 patients treated at our institute to evaluate the practical and prognostic value of the TNM-classification. We found that, using the current classification system, accurate clinical staging is often difficult, because the T and N categories are defined by structures that are not easily identified using physical examination or imaging. Furthermore, the prognostic stratification of the present staging system is not optimal and there is a substantial overlap in disease-specific survival between several categories. We give an overview of modifications that could improve clinical staging and prognostic ability. The current TNM classification for penile carcinoma has several shortcomings in terms of usability in clinical staging and prognostic value. With modifications clinical staging is facilitated, while the prognostic stratification of the classification is improved.